Core Points - The company will hold its first extraordinary general meeting of shareholders in 2025 on October 23, 2025 [2][3] - The meeting will utilize the Shanghai Stock Exchange's online voting system for A-share shareholders [2][4] - The meeting will take place at Shanghai Tianxi Jiafu Putike Hotel, starting at 13:30 [3] Meeting Details - The meeting is convened by the board of directors [3] - A-share shareholders can vote both on-site and online [3] - The online voting will be available during specific trading hours on the day of the meeting [4] Voting Procedures - A-share shareholders must follow specific procedures for voting through margin trading and other accounts [5] - There are no applicable provisions for public solicitation of shareholder voting rights [6] - The voting results will be based on the first vote cast if multiple votes are submitted [11] Agenda Items - The meeting will review several proposals that have been previously disclosed [7] - Special resolutions will include proposals 1 to 5, with separate counting for small investors [8] - Certain shareholders are required to abstain from voting on specific proposals due to conflicts of interest [8][9] Attendance Information - A-share shareholders must register to attend the meeting, either online or on-site [12][15] - H-share shareholders have separate registration procedures detailed on the Hong Kong Stock Exchange website [14][19] - All expenses related to attending the meeting are to be borne by the shareholders themselves [21] Contact Information - Shareholders can contact the company's board secretary office for further inquiries [22][25]

Core Viewpoint - The company has established a long-term incentive mechanism to ensure the successful implementation of the 2025 A-share option plan, aiming to enhance management performance and maximize shareholder interests [1][2]. Group 1: Assessment Objectives and Principles - The purpose of the assessment is to improve corporate governance and establish a long-term incentive mechanism to ensure the achievement of the company's strategic and operational goals by 2025 [1]. - The assessment must adhere to principles of fairness, openness, and impartiality, linking the A-share option plan closely with the performance and contributions of the incentivized individuals [1][2]. Group 2: Assessment Scope and Organization - The assessment applies to all individuals participating in the 2025 A-share option plan [1]. - The company's Board of Directors' Compensation and Assessment Committee will lead and organize the assessment work [1]. Group 3: Assessment Indicators and Standards - The assessment will evaluate the company's financial performance indicators annually, focusing on "net profit attributable to shareholders" and "revenue from innovative drugs" [1][2]. - Specific targets for the assessment indicators include a net profit target of 33.2 billion RMB for the first year, increasing to 39.6 billion RMB and 47.7 billion RMB in subsequent years [2][3]. Group 4: Assessment Period and Frequency - The assessment period spans from 2025 to 2027, with evaluations conducted annually [3][4]. Group 5: Assessment Procedures and Results Management - The Human Resources Department, under the guidance of the Compensation and Assessment Committee, is responsible for the assessment process and maintaining the results [4]. - Incentivized individuals have the right to understand their assessment results and can appeal if they disagree with the evaluations, following the established procedures [4].